Neef C, Keulemans K T, Meijer D K
Biochem Pharmacol. 1984 Dec 15;33(24):3977-90. doi: 10.1016/0006-2952(84)90011-x.
Three quaternary ammonium compounds (QACs) with different lipophilicity, triethylmethyl ammonium iodide (TEMA), tripropylmethyl ammonium iodide (TPMA) and tri-n-butylmethyl ammonium iodide (TBuMA) were given as a bolus injection of 10 mumole and 1 mumole in an isolated perfused liver. TPMA and TBuMA exhibited saturation kinetics at a dose of 10 mumole, but not when 1 mumole of the agents was given. Biliary clearance of TEMA was equal to the bile flow (0.010 ml/min), whereas for TPMA and TBuMA much higher values of 0.8 ml/min and 2.2 ml/min were found respectively. Partition coefficients of TEMA, TPMA and TBuMA between n-octanol and Krebsbicarbonate solution were 0.0013, 0.013 and 0.14 respectively. Liver-to-plasma concentration ratios were 4, 16 and 30 in the post-distribution phase, whereas bile-to-liver ratios were calculated to be 0.1, 1.3 and 14 respectively. The latter parameter varied roughly proportionally to the lipophilicity of the compounds. The liver/plasma concentration ratios corrected for intracellular binding exceeded a value of 12 indicating that accumulation in the liver of these agents cannot soley be explained by passive equilibration according to the membrane potential. Transport from liver into the bile of TPMA and TBuMA presumably also occurred against an electrochemical gradient. It was inferred that the small molecular weight compounds such as TEMA, can be transported from plasma into bile paracellularly by a passive process. Rapid uptake into the liver of such compounds may not lead to an appreciable biliary output and can even reduce the rate of biliary excretion. QACs with intermediate or high lipophilicity are transported by carrier mediated processes both at the level of hepatocyte uptake and bile canalicular transport. The influence of choleresis on hepato-biliary transport of the three QACs was investigated by giving sodium taurocholate (Tc) by constant infusion of 60 mumole/hr, increasing bile flow from 9 to 16 microliter/min. The biliary output of TEMA appeared to be basically unaffected, whereas the biliary excretion of TPMA and TBuMA was clearly elevated when the bile flow was increased. The stimulatory influence of taurocholate on the biliary output of the latter organic cations is explained by an increased net uptake of these agents into the liver and an increased net canalicular transport. This effect is proposed to be due to a reduced reabsorption from the biliary tree as a consequence of the higher bile flow and/or biliary micelle binding. Taurocholate increased liver-to-plasma ratios.(ABSTRACT TRUNCATED AT 400 WORDS)
将三种具有不同亲脂性的季铵化合物(QACs),即碘化三乙甲基铵(TEMA)、碘化三丙甲基铵(TPMA)和碘化三正丁基甲基铵(TBuMA),以10微摩尔和1微摩尔的剂量在离体灌注肝脏中进行单次注射。在剂量为10微摩尔时,TPMA和TBuMA呈现饱和动力学,但给予1微摩尔药物时则未出现。TEMA的胆汁清除率与胆汁流量相等(0.010毫升/分钟),而对于TPMA和TBuMA,分别发现其值高得多,为0.8毫升/分钟和2.2毫升/分钟。TEMA、TPMA和TBuMA在正辛醇和 Krebs 碳酸氢盐溶液之间的分配系数分别为0.0013、0.013和0.14。在分布后阶段,肝与血浆的浓度比分别为4、16和30,而胆汁与肝脏的浓度比经计算分别为0.1、1.3和14。后一参数大致与化合物的亲脂性成比例变化。校正细胞内结合后的肝/血浆浓度比超过12,表明这些药物在肝脏中的蓄积不能仅通过根据膜电位的被动平衡来解释。TPMA和TBuMA从肝脏向胆汁的转运可能也是逆电化学梯度进行的。据推测,小分子重量的化合物如TEMA,可以通过被动过程经细胞旁途径从血浆转运到胆汁中。此类化合物快速摄取到肝脏中可能不会导致可观的胆汁排出,甚至可能降低胆汁排泄速率。具有中等或高亲脂性的QACs在肝细胞摄取和胆小管转运水平均通过载体介导的过程进行转运。通过以60微摩尔/小时的恒定输注速率给予牛磺胆酸钠(Tc),使胆汁流量从9微升/分钟增加到16微升/分钟,研究了胆汁分泌对三种QACs肝-胆转运的影响。TEMA的胆汁排出似乎基本未受影响,而当胆汁流量增加时,TPMA和TBuMA的胆汁排泄明显升高。牛磺胆酸盐对后两种有机阳离子胆汁排出的刺激作用可通过这些药物进入肝脏的净摄取增加和胆小管净转运增加来解释。推测这种作用是由于胆汁流量增加和/或胆汁微团结合导致从胆管树的重吸收减少所致。牛磺胆酸盐增加了肝与血浆的浓度比。(摘要截短至400字)